Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Colorado MEDtech, CMED -- Ignore unavailable to you. Want to Upgrade?

To: Starfish* who wrote (149)	11/24/1998 1:29:00 PM
From: Paul K	Respond to of 288

"Colorado MEDtech Inc. Obtains Orders for its Medical Device Year 2000 Compliance Service" Business Wire - November 23, 1998 10:38 BOULDER, Colo.--(BW HealthWire)--Nov. 23, 1998-- Colorado MEDtech, Inc. (NASDAQ:CMED), a Boulder, Colorado-based medical products and outsourcing services company, today announced that its wholly-owned subsidiary, BioMed Y2K, Inc. ("BioMed"), has already received orders totaling more than $1.5 million from several healthcare providers to assist them in evaluating medical devices for Year 2000 ("Y2K") compliance. In April 1998, BioMed created a software system called BioMed Y2K One(tm) that offers a combination of tools and services to support healthcare institutions' efforts to establish Y2K compliance for their biomedical devices. BioMed Y2K, Inc. has been selected by some of the nation's most prestigious facilities, including Cleveland Clinic, Westchester County Hospital (New York) and Vencor, Inc. In addition to this group, several other hospitals have selected BioMed for their Y2K compliance work. "We are pleased to have been chosen as the preferred Y2K solutions provider for this distinguished group of healthcare providers and institutions," said John V. Atanasoff, President and Chief Executive Officer of Colorado MEDtech, Inc. "Our proprietary database for Y2K compliance reviews now consists of over 16,000 unique medical devices. We attribute the success and acceptance of our Y2K program to our years of experience with medical device software and embedded technologies. As a performance leader in medical device products and outsourcing services, we are committed to our customers' success." Colorado MEDtech, Inc., through its wholly-owned affiliates and operating divisions, is a leading full-service provider of advanced medical products and comprehensive outsourcing services for medical device and pharmaceutical companies. CONTACT: Colorado MEDtech, Inc. John V. Atanasoff, President and CEO Bruce L. Arfmann, CFO Telephone: 303/530-2660 Fax: 303/581-1010 Website: cmed.com Email: cmedinfo@cmed.com

To: Starfish* who wrote (149)	11/24/1998 1:30:00 PM
From: Paul K	Read Replies (1) \| Respond to of 288

M.H. Meyerson & Co., Inc. Continues to Rate Colorado MEDTech, Inc. (Nasdaq: CMED) a Strong Buy PR Newswire - November 24, 1998 13:12 JERSEY CITY, N.J., Nov. 24 /PRNewswire/ -- The following is being issued by M.H. Meyerson & Co., Inc., a member of the National Association of Securities Dealers, CRD number 540: M.H. Meyerson & Co., Inc., (Nasdaq: MHMY) announced it continues to rate Colorado MEDTech, Inc. (Nasdaq: CMED) a "STRONG BUY." A Research Brief is available. The report was prepared by Andrew H. Scott of M.H. Meyerson & Co., Inc., 525 Washington Blvd., Jersey City, New Jersey 07310. For more information, contact Andrew H. Scott at 201-459-9440 or 800-422-4114; web site: www.mhmeyerson.com. SOURCE M.H. Meyerson & Co., Inc. /CONTACT: Andrew H. Scott of M.H. Meyerson & Co., Inc., 201-459-9440 or 800-422-4114/ /Web site: mhmeyerson.com